Categories:
Articles
Blog
Exploring the transformative potential of R Shiny, an open-source web application, in visualizing tumor data evaluation based on RECIST 1.1 criteria for patient-specific insights and early detection.
With the significant time and cost invested in bringing an Oncology therapy to market, biopharma companies are constantly investing in enhancing decision-making and patient outcomes. While RECIST offers a standardized methodology for measuring therapy response in solid tumors, download this whitepaper where we discuss how purpose-built visualization can revolutionize tumor evaluation and streamline insight generation.